587 related articles for article (PubMed ID: 10843166)
1. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
2. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
3. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
11. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
12. A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism and hypertensive disease.
Mosso L; Carvajal C; González A; Barraza A; Avila F; Montero J; Huete A; Gederlini A; Fardella CE
Hypertension; 2003 Aug; 42(2):161-5. PubMed ID: 12796282
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
16. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
[TBL] [Abstract][Full Text] [Related]
17. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction.
Yokota K; Ogura T; Kishida M; Suzuki J; Otsuka F; Mimura Y; Oishi T; Hirata M; Tobe K; Makino H
Hypertens Res; 2001 Sep; 24(5):589-94. PubMed ID: 11675955
[TBL] [Abstract][Full Text] [Related]
18. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
Aglony M; Martínez-Aguayo A; Carvajal CA; Campino C; García H; Bancalari R; Bolte L; Avalos C; Loureiro C; Trejo P; Brinkmann K; Giadrosich V; Mericq V; Rocha A; Avila A; Perez V; Inostroza A; Fardella CE
Hypertension; 2011 Jun; 57(6):1117-21. PubMed ID: 21502562
[TBL] [Abstract][Full Text] [Related]
19. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
